World News | Suzi Ring, James Paton and Stephanie Baker, Bloomberg | Wednesday December 9, 2020
On the day Britain began immunizing its population with a Covid-19 shot developed by Germany's BioNTech SE and the U.S.'s Pfizer Inc., a peer-reviewed study of the U.K.'s homegrown vaccine left some key questions unanswered.
www.ndtv.com